AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PARADIGM BIOPHARMACEUTICALS

0.175

0.000

Volume:1.74M

Turnover:307.66K

Market Cap:104.86M

PE:-1.67

High:0.180

Open:0.180

Low:0.175

Close:0.175

52wk High:0.470

52wk Low:0.135

Shares:599.19M

Float Shares:353.07M

Volume Ratio:0.75

T/O Rate:0.49%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.105

EPS(LYR):-0.060

ROE:-180.22%

ROA:-82.94%

PB:17.48

PE(LYR):-2.93

Loading ...

Overview Company News Filings

Company Profile

Company Name:

PARADIGM BIOPHARMACEUTICALS

Exchange:

ASX

Establishment Date:

2014

Employees:

- -

Office Location:

500 Collins Street,Level 15,Melbourne,Victoria,Australia

Website:

http://www.paradigmbiopharma.com

Zip Code:

3000

Phone:

Fax:

61 3 9629 5466

Introduction:

Paradigm Biopharmaceuticals Limited, a biopharmaceutical company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulphate sodium drugs in the injectable and tablet forms for the treatment of bone marrow edema, respiratory, and alphaviral arthritis diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/PAR.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PAR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PAR.AU\",,,,,undefined,":{"symbol":"PAR.AU","market":"AU","secType":"STK","nameCN":"PARADIGM BIOPHARMACEUTICALS","latestPrice":0.175,"timestamp":1787292720000,"preClose":0.175,"halted":0,"volume":1743408,"delay":0,"changeRate":0,"nameEN":"PARADIGM BIOPHARMACEUTICALS","floatShares":353065639,"shares":599189900,"eps":-0.10495,"marketStatus":"Market Closed","change":0,"latestTime":"08-21 16:12:00 AEST","open":0.18,"high":0.18,"low":0.175,"amount":307657,"amplitude":0.028571,"askPrice":0.175,"askSize":43404,"bidPrice":0.17,"bidSize":781260,"shortable":3,"etf":0,"ttmEps":-0.10495,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.175,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.7489169664439258,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"PAR.AU","preClose":0.175,"auctionPrice":0.175,"auctionVolume":106956,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292600772}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PAR.AU\",,,,,undefined,":{"symbol":"PAR.AU","floatShares":353065639,"roa":"-82.94%","roe":"-180.22%","lyrEps":-0.059684,"volumeRatio":0.7489169664439258,"shares":599189900,"dividePrice":0,"high":0.18,"amplitude":0.028571,"preClose":0.175,"low":0.175,"week52Low":0.135,"pbRate":"17.48","psRate":"12409.26","week52High":0.47,"institutionHeld":0,"latestPrice":0.175,"committee":0.894735,"eps":-0.10495,"divideRate":0,"volume":1743408,"delay":0,"ttmEps":-0.10495,"open":0.18,"prevYearClose":0.34,"prevWeekClose":0.18,"prevMonthClose":0.165,"prevQuarterClose":0.165,"fiveDayClose":0.18,"twentyDayClose":0.165,"sixtyDayClose":0.165,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PAR.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-02-06","symbol":"PAR.AU","defaultRemindTime":1738796400000,"type":"split","dateTimestamp":1738760400000,"forFactor":4,"toFactor":5,"ratio":0.8},{"market":"AU","date":"2022-08-17","symbol":"PAR.AU","defaultRemindTime":1660694400000,"type":"split","dateTimestamp":1660658400000,"forFactor":992772,"toFactor":1000000,"ratio":0.992772}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PAR.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":276414891,"yearFounded":2014,"address":"500 Collins Street,Level 15,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9629 5566","officeFax":"61 3 9629 5466","fiscalYearEnd":"06-30"},"stockCompanyDetail":{"websiteUrl":"http://www.paradigmbiopharma.com","stockEarnings":[{"period":"1week","weight":-0.0278},{"period":"1month","weight":0},{"period":"3month","weight":0.0294},{"period":"6month","weight":-0.375},{"period":"1year","weight":-0.4262},{"period":"ytd","weight":-0.4853}],"compareEarnings":[{"period":"1week","weight":-0.0013},{"period":"1month","weight":0.0219},{"period":"3month","weight":0.0512},{"period":"6month","weight":0.0313},{"period":"1year","weight":0.0865},{"period":"ytd","weight":0.0535}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Paradigm Biopharmaceuticals Limited, a biopharmaceutical company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulphate sodium drugs in the injectable and tablet forms for the treatment of bone marrow edema, respiratory, and alphaviral arthritis diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.272727,"avgChangeRate":-0.078902},{"month":2,"riseRate":0.454545,"avgChangeRate":0.019659},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.033069},{"month":4,"riseRate":0.454545,"avgChangeRate":0.070789},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.031471},{"month":6,"riseRate":0.545455,"avgChangeRate":0.061432},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.024877},{"month":8,"riseRate":0.545455,"avgChangeRate":0.112354},{"month":9,"riseRate":0.545455,"avgChangeRate":0.040273},{"month":10,"riseRate":0.545455,"avgChangeRate":0.131474},{"month":11,"riseRate":0.181818,"avgChangeRate":-0.081789},{"month":12,"riseRate":0.454545,"avgChangeRate":0.065089}],"exchange":"ASX","name":"PARADIGM BIOPHARMACEUTICALS","nameEN":"PARADIGM BIOPHARMACEUTICALS"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PAR.AU\",market:\"AU\",,,undefined,":null}}